Practical development of a novel method for hematopoietic stem cell expansion
Practical development of a novel method for hematopoietic stem cell expansion
批准号:
09357010
负责人:
HIRAI Hisamaru
金额:
$18.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
Delta/Serrate/LAG-2(DSL)域含有的蛋白质被认为是Notch受体的配体。However,DSL蛋白质和Notch受体之间的物理相互作用很难理解。We found that mJagged1 physically bound to mouse Notch2 (mNotch2) on the cell surface and to a purified extracellular portion of mNotch2, respectively, in a Cay D22+-D2 dependent manner。显示mJagged 1的DSL域是一个最小的绑定单元,并且是独立的绑定到mNotch 2。固体相位绑定测试显示,Jagged 1绑定到Notch 1和Notch 3,添加到Notch 2,建议mJagged 1是多个Notch接收器的一种装配。我们进一步分析了转录因子的表达水平,如C/EBP α、C/EBPε、PU.1、AML 1b、c-myb和GATA-2,以及SCL、GATA-1、GATA-2、NF-E2 (第45页)、MafK (第18页)、EKLF和c-myb(第18页)等异常转录因子,对野生型和aNotch 1 - 32 D骨髓瘤细胞和F5-5红细胞的差异进行刺激之前和之后的刺激,尊重地。作为一个结果,那些转录因子的表达水平除了GATA-2显示了野生类型和aNotch 1-表达的相同模式,在发现了GATA-2的表达水平之外,在aNotch 1-表达的32 D细胞中的差异刺激后,发现了未改变的激励水平,通过aNotch 1通过GATA-2进行了调节。
英文摘要
The Delta/Serrate/LAG-2 (DSL) domain-containing proteins are considered to be ligands for Notch receptors. However, the physical interaction between DSL proteins and Notch receptors is poorly understood. We found that mJagged1 physically bound to mouse Notch2 (mNotch2) on the cell surface and to a purified extracellular portion of mNotch2, respectively, in a CaィイD22+-ィエD2dependent manner. Deletion mutant analyses showed that the DSL Domain of mJagged1 is a minimal binding unit and is indispensable for binding to mNotch2. The solid-phase binding assay showed that Jagged1 binds to Notch1 and Notch3 in addition to Notch2, suggesting that mJagged1 is a ligand for multiple Notch receptors. We further analyzed the expression levels of transcription factors, C/EBP α, C/EBPε, PU.1, AML1b, c-myb, and GATA-2 as myeloid-specific transcription factors, and SCL, GATA-1, GATA-2, NF-E2 (p45), MafK (p18), EKLF, and c-myb as erythroid-specific transcription factors, before and after stimulation for differentiation of the wild-type and aNotch1-expressing 32D myeloid cells and F5-5 erythroid cells, respectively. As a result, the expression levels of those transcription factors except GATA-2 showed the same pattern in the wild-type and aNotch1-expressing cells, whereas the expression level of GATA-2 was found unchanged after stimulation for differentiation in the aNotch1-expressing 32D cells but decreased in the wild-type cells, suggesting inhibition of differentiation by aNotch1 is mediated through GATA-2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tanaka K: "The AML1/ETO (MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2β (CBFβ) in the nucleus more efficiently than wild-type AML1." Blood. 91. 1688-1699 (1998)
Tanaka K:“AML1/ETO (MTG8) 和 AML1/Evi-1 白血病相关嵌合癌蛋白比野生型 AML1 更有效地在细胞核中积累 PEBP2β (CBFβ)。” 91. 1688-1699 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kurokawa M: "The t (3 ; 21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks TGFβ-mediated growth inhibition of myeloid cells." Blood. 92. 4003-4012 (1998)
Kurokawa M:“t (3; 21) 融合产物 AML1/Evi-1 与 Smad3 相互作用并阻断 TGFβ 介导的骨髓细胞生长抑制。” Blood。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimizu K: "Mouse Jagged1 physically interacts with Notch2 and other Notch receptors : assessment by quantitative metnods"J. Biol. Chem.. 274. 32961-32969 (1999)
Shimizu K:“小鼠 Jagged1 与 Notch2 和其他 Notch 受体发生物理相互作用:通过定量方法进行评估”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chiba S: "Selective expression of mRNA coding for truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera." Blood. 90. 97-104 (1997)
Chiba S:“造血细胞中编码截短形式促红细胞生成素受体的 mRNA 的选择性表达及其在真性红细胞增多症患者中的减少。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakamoto T: "CIZ : a zinc finger protein that interacts with p130cas and activates the expression of matrix metalloproteinases"Mol. Cell. Biol.. (In press).
Nakamoto T:“CIZ:一种锌指蛋白,与 p130cas 相互作用并激活基质金属蛋白酶的表达”Mol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 30 条
Analyses of Maltipotential Functions of a Novel Signaling Molecule, Cas
-
批准号:11694250
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$5.57万
-
财政年份:1999
-
负责人:HIRAI Hisamaru
-
依托单位:
Analyses of a Novel Signaling Molecule, Cas
-
批准号:09044271
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.44万
-
财政年份:1997
-
负责人:HIRAI Hisamaru
-
依托单位:
Analysis of molecular mechanisms of leukemia development
-
批准号:09307021
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$24.58万
-
财政年份:1997
-
负责人:HIRAI Hisamaru
-
依托单位:
Analysis of Molecular Mechanism of Blastic Crisis in Chronic Myelocytic Leukemia
-
批准号:07042002
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.65万
-
财政年份:1995
-
负责人:HIRAI Hisamaru
-
依托单位:
Functional analysis of AML1 gene in normal hematopoietic cells and leukemia cells
-
批准号:07457229
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1995
-
负责人:HIRAI Hisamaru
-
依托单位:
Molecular analysis of leukemias with chromosomal translocation and its application for clinical Diagnosis
-
批准号:05454328
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1993
-
负责人:HIRAI Hisamaru
-
依托单位:
Molecular Diagnosis of Human Leukemias
-
批准号:04253208
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$12.16万
-
财政年份:1992
-
负责人:HIRAI Hisamaru
-
依托单位:
Development and clinical application of molecular diagnosis in leukemias
-
批准号:04557133
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$9.73万
-
财政年份:1992
-
负责人:HIRAI Hisamaru
-
依托单位:
Analysis of signal transduction mechanism through a novel tyrosine kinase receptor
-
批准号:03454521
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1991
-
负责人:HIRAI Hisamaru
-
依托单位: